IDiyas

For the Inventor, By the Inventor

Lardy, France

Jean-Claude Monier

USPTO Granted Patents = 17

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 101(Granted Patents)


Company Filing History:

goldMedal8 out of 31 
 
Societe D'etudes Scientifiques Et Industrielles De L'ile-de-france
 patents
silverMedal1 out of 1 
 
Societe De'etudes Scientifiques Et Industrielles De L'ile-de France
 patent
bronzeMedal1 out of 1 
 
Laboratoires Delagrange Div. Societe D'applications Pharmacodynamiques
 patent
4. 1 out of 1 
 
Societe D'etudes Scientifiques Et Industrielle De L'ile De France
 patent
5. 1 out of 1 
 
Societe D'etudes Scientifiques Et Industrielle De L'ile-d-france
 patent
6. 1 out of 1 
 
Societe D'etudes Scientifiques Et Industrielles De L'ille-de France
 patent
7. 1 out of 1 
 
Societe D'etudes Scientifiques Et Industrielles De L'ile-d-france
 patent
8. 1 out of 1 
 
Laboratoires Delagrange (synthelabo)
 patent
9. 1 out of 1 
 
Laboratoires Delagrange Societe D'application Pharmacodynamiques
 patent
10. 1 out of 1 
 
Laboratoires Delagrange Societe D'applications Pharmacodnymiques
 patent

Years Active: 1976-1992

Loading Chart...
17 patents (USPTO):Explore Patents
1. 5141949 - Method of providing anxiolytic and antipsychotic treatment (1992-08-25),
2. 5116859 - Method of providing anxiolytic and antipsychotic treatment (1992-05-26),
3. 5116857 - Method of increasing gastrointestinal motility with substituted (1992-05-26),
4. 5110824 - Method of treating disorders of cognitive function with substituted (1992-05-05),
5. 5086066 - Method of providing anxiolytic and antipsychotic treatment with (1992-02-04),
6. 4914117 - Novel benzamides, intermediates and process for the preparation and (1990-04-03),
7. 4835172 - Novel benzamides, intermediates and process for the preparation and (1989-05-30),
8. 4816471 - Substituted heterocyclic benzamides, methods of preparing them and their (1989-03-28),
9. 4804765 - Process for synthesizing N-[(1'-allyl-2'pyrrolidinyl) (1989-02-14),
10. 4673686 - New substituted heterocyclic benzamides, methods of preparing them and (1987-06-16),
11. 4401822 - Derivatives of 4-amino-5-alkyl sulphonyl orthoanisamides (1983-08-30),
12. 4294828 - New derivatives of 4-amino-5-alkyl sulphonyl orthoanisamides, methods of (1981-10-13),
13. 4166060 - Process for producing enamines (1979-08-28),
14. 4077976 - Enamines, their derivatives and processes of production (1978-03-07),
15. 4039672 - N-(1'-Allypyrrolidinyl 2'-methyl) 2-methoxy 4,5-azimido benzamide and (1977-08-02),

Title: Inventor Spotlight: Jean-Claude Monier

Introduction

Jean-Claude Monier, an innovative inventor based in Lardy, France, has made significant contributions to the field of pharmaceuticals with a total of 17 patents to his name. His research and inventions focus primarily on the realm of anxiolytic and antipsychotic treatments, showcasing his dedication to advancing medical science.

Latest Patents

Among his latest innovations, Monier developed a method for providing anxiolytic and antipsychotic treatment. This method involves administering therapeutically effective amounts of N-[2-(diethylamino)-ethyl]-2-methoxy-4-[(1-H-4,5-dihydro-2-imidazolyl)-amino]-5-chlorobenzamide, or a pharmaceutically acceptable salt thereof. Additionally, he has also introduced a method for increasing gastrointestinal motility using substituted benzamides, demonstrating the versatility and applicability of his research in various medical fields.

Career Highlights

Monier's impressive career includes pivotal roles at notable companies such as Société d'Études Scientifiques et Industrielles de L'Île-de-France. His experience in these organizations has not only contributed to his personal development but has also led to groundbreaking advancements in pharmaceutical science, further establishing his reputation as a prominent inventor.

Collaborations

Throughout his career, Jean-Claude Monier has collaborated with esteemed colleagues, including Jacques Acher and Jean-Paul Schmitt. These partnerships have played a crucial role in augmenting the scope and impact of his inventions, fostering a collaborative environment that promotes innovation in the healthcare sector.

Conclusion

Jean-Claude Monier's impactful work continues to influence the landscape of pharmaceuticals and treatment methodologies. With 17 patents highlighting his ingenuity and collaboration with fellow professionals, he remains an essential figure in the realm of medical inventions, striving to improve patient outcomes and contribute to the future of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…